Table 2 Baseine characteristics (age, sex, percentage predicted Forced expiratory rate in the first second (FEV1), Inhaled Cosirosteroid (ICS) dose in mcg/dat beclomethasone equivalent, ciuurent smoking status in groups randomsied to AKL followed by placebo or to placebo followed by AKL, with p values for differences between groups.
age (median, IQR) | Female sex (n) | FEV1 % predicted (median, IQR) | ICS dose, mcg/day (median, IQR) | Current smoker (n) | |
|---|---|---|---|---|---|
AKL1 – Placebo (n = 16) | 41.00, 33.50 – 55.75 | 13 | 90.00, 79.75 – 115.50 | 1000, 400 – 2000 | 1 |
Placebo – AKL1 (n = 16) | 35.50, 29.50 – 55.50 | 12 | 85.50, 56.50 – 110.00 | 800, 400 – 1150 | 1 |
P value | 0.67 | 0.67 | 0.25 | 0.51 | 1.00 |